Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-05-01 00:00:00 ET · period of report 2025-04-29 · accession 0001415889-25-011690 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-01 | 2025-04-29+ | KNSA | Ragosa Mark | CFO | M - OptEx | $16.51 | +88.4K | 47.0K | New | +$1.46M |
| DM | 2025-05-01 | 2025-04-29+ | KNSA | Ragosa Mark | CFO | S - Sale+OE | $26.56 | -88.4K | 27.0K | -77% | -$2.35M |
| DM | 2025-05-01 | 2025-04-29+ | KNSA | Ragosa Mark | CFO | M - OptEx | $0.00 | -88.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-05-01 | M | A | 13,141 | $17.76 | 52,150 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-05-01 | M | A | 12,000 | $17.92 | 39,009 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-04-30 | S | D | 21,254 | $26.95 | 27,009 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2025-04-30 | M | A | 21,254 | $16.90 | 48,263 | D | — | — | |
| 5 | Common | Class A Ordinary Share | 2025-04-29 | S | D | 42,000 | $25.61 | 27,009 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $25.50 and $25.935. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 6 | Common | Class A Ordinary Share | 2025-04-29 | M | A | 22,000 | $15.50 | 69,009 | D | — | — | |
| 7 | Common | Class A Ordinary Share | 2025-04-29 | M | A | 20,000 | $15.52 | 47,009 | D | — | — | |
| 8 | Common | Class A Ordinary Share | 2025-05-01 | S | D | 25,141 | $27.80 | 27,009 | D | — | — | |
| 9 | Derivative | Share Option | 2025-05-01 | M | D | 13,141 | $0.00 | 28,909 | D | $17.76 · — to 2033-08-31 | 13,141 Class A Ordinary Share | (F4) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023. |
| 10 | Derivative | Share Option | 2025-05-01 | M | D | 12,000 | $0.00 | 0 | D | $17.92 · — to 2029-03-03 | 12,000 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |
| 11 | Derivative | Share Option | 2025-04-30 | M | D | 21,254 | $0.00 | 2,471 | D | $16.90 · — to 2031-04-25 | 21,254 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |
| 12 | Derivative | Share Option | 2025-04-29 | M | D | 22,000 | $0.00 | 0 | D | $15.50 · — to 2030-09-09 | 22,000 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |
| 13 | Derivative | Share Option | 2025-04-29 | M | D | 20,000 | $0.00 | 0 | D | $15.52 · — to 2030-03-12 | 20,000 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |